{"id":"testogel-1","safety":{"commonSideEffects":[{"rate":"null","effect":"Application site reactions"},{"rate":"null","effect":"Skin irritation"},{"rate":"null","effect":"Allergic reactions"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"Testosterone replacement therapy with Testogel 1% aims to restore normal testosterone levels in men with hypogonadism, which can lead to symptoms such as low libido, fatigue, and decreased muscle mass. The gel is applied topically to the skin, allowing for controlled release of testosterone into the bloodstream.","oneSentence":"Testogel 1% is a topical testosterone gel used to treat hypogonadism in males.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:54:05.050Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Treatment of hypogonadism in males"}]},"trialDetails":[{"nctId":"NCT04492553","phase":"PHASE2","title":"Gonadal Dysfunction in Male Long-term Survivors of Malignant Lymphoma; Vitality","status":"COMPLETED","sponsor":"Lars Møller Pedersen","startDate":"2021-04-01","conditions":"Hypogonadism","enrollment":7},{"nctId":"NCT00190060","phase":"PHASE4","title":"Study of The Effects of Testosterone in Frail Elderly Men","status":"COMPLETED","sponsor":"Manchester University NHS Foundation Trust","startDate":"2004-10","conditions":"Frailty, Sarcopenia","enrollment":262},{"nctId":"NCT01292785","phase":"","title":"Effects of Sex Steroid Hormones on Human Brain Function, Structure and Connectivity","status":"COMPLETED","sponsor":"Medical University of Vienna","startDate":"2011-01","conditions":"Gender Identity Disorder","enrollment":80},{"nctId":"NCT00185198","phase":"PHASE3","title":"Efficacy and Safety of Testogel® in Men With Partial Androgen Deficiency of Aging Males (PADAM)","status":"COMPLETED","sponsor":"Bayer","startDate":"2004-09","conditions":"Androgens (Deficiency), Male","enrollment":363},{"nctId":"NCT00847314","phase":"","title":"Efficacy and Tolerability of Testogel/Nebido in Combination With Exercise and Diet in Hypogonadal Male Patients","status":"COMPLETED","sponsor":"Bayer","startDate":"2007-06","conditions":"Hypogonadism","enrollment":30},{"nctId":"NCT01786473","phase":"PHASE3","title":"Testogel® (Testosterone Gel 50mg/5g) in the Treatment of Male Hypogonadism","status":"UNKNOWN","sponsor":"Laboratoires Besins International","startDate":"2012-12","conditions":"Hypogonadism","enrollment":240},{"nctId":"NCT00613288","phase":"NA","title":"Testosterone and Lipolysis, Insulin Sensitivity and Protein Metabolism","status":"COMPLETED","sponsor":"University of Aarhus","startDate":"2007-09","conditions":"Hypogonadism","enrollment":12},{"nctId":"NCT00244023","phase":"PHASE3","title":"Co-Administering Testosterone With PDE5 Inhibitors in ED Patients Non Responders to PDE5 Inhibitors Alone","status":"COMPLETED","sponsor":"SELARL du Dr Jacques BUVAT","startDate":"2005-10","conditions":"Erectile Dysfunction, Hypogonadism","enrollment":173}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"Testogel 1%","genericName":"Testogel 1%","companyName":"Laboratoires Besins International","companyId":"laboratoires-besins-international","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Testogel 1% is a topical testosterone gel used to treat hypogonadism in males. Used for Treatment of hypogonadism in males.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}